These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Liver biopsy interpretation for causes of late liver allograft dysfunction. ; Demetris AJ; Adeyi O; Bellamy CO; Clouston A; Charlotte F; Czaja A; Daskal I; El-Monayeri MS; Fontes P; Fung J; Gridelli B; Guido M; Haga H; Hart J; Honsova E; Hubscher S; Itoh T; Jhala N; Jungmann P; Khettry U; Lassman C; Ligato S; Lunz JG; Marcos A; Minervini MI; Mölne J; Nalesnik M; Nasser I; Neil D; Ochoa E; Pappo O; Randhawa P; Reinholt FP; Ruiz P; Sebagh M; Spada M; Sonzogni A; Tsamandas AC; Wernerson A; Wu T; Yilmaz F Hepatology; 2006 Aug; 44(2):489-501. PubMed ID: 16871565 [TBL] [Abstract][Full Text] [Related]
25. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium. Ruiz P; Bagni A; Brown R; Cortina G; Harpaz N; Magid MS; Reyes J Transplant Proc; 2004 Mar; 36(2):335-7. PubMed ID: 15050150 [TBL] [Abstract][Full Text] [Related]
26. Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: reliability of the 1999 Banff schema. Sebagh M; Blakolmer K; Falissard B; Roche B; Emile JF; Bismuth H; Samuel D; Reynès M Hepatology; 2002 Jan; 35(1):117-25. PubMed ID: 11786967 [TBL] [Abstract][Full Text] [Related]
27. Spectrum of histopathological changes in pancreas allograft biopsies and relationship to graft loss. Drachenberg CB; Papadimitriou JC Transplant Proc; 2007 Sep; 39(7):2326-8. PubMed ID: 17889178 [TBL] [Abstract][Full Text] [Related]
28. Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome. Masin-Spasovska J; Spasovski G; Dzikova S; Grcevska L; Petrusevska G; Lekovski Lj; Popov Z; Ivanovski N Transplant Proc; 2005 Mar; 37(2):705-8. PubMed ID: 15848508 [TBL] [Abstract][Full Text] [Related]
29. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis. Papadimitriou J; Drachenberg C; Anderson L; Bartlett S; Johnson L; Klassen D; Hoehn-Saric E; Weir M; Schweitzer E Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334 [No Abstract] [Full Text] [Related]
30. Reversibility from delayed hyperacute rejection in ABO-incompatible renal transplantation: histopathological findings of renal allograft biopsy. Sugiyama K; Arai K; Aikawa A; Miyagi M; Ohara T; Hasegawa A; Muramatsu M; Hirayama N; Tajima E; Kawamura T; Ogihara H; Hadano T; Nakano H Transplant Proc; 2005 Mar; 37(2):701-4. PubMed ID: 15848507 [TBL] [Abstract][Full Text] [Related]
31. Liver allograft pathology in liver/small bowel or multivisceral recipients. Tsamandas AC; Furukawa H; Abu-Elmagd K; Todo S; Demetris AJ; Lee RG Transplant Proc; 1996 Oct; 28(5):2772. PubMed ID: 8908051 [No Abstract] [Full Text] [Related]
32. Early histopathologic features of tracheal allotransplant rejection: a study in nonimmunosuppressed dogs. Nakanishi R; Shirakusa T; Hanagiri T Transplant Proc; 1994 Dec; 26(6):3715-8. PubMed ID: 7998328 [No Abstract] [Full Text] [Related]
33. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. Yousem SA; Berry GJ; Cagle PT; Chamberlain D; Husain AN; Hruban RH; Marchevsky A; Ohori NP; Ritter J; Stewart S; Tazelaar HD J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):1-15. PubMed ID: 8820078 [TBL] [Abstract][Full Text] [Related]
35. Borderline changes in the Banff schema: rejection or no rejection? Gaber LW Transplant Proc; 2004 Apr; 36(3):755-7. PubMed ID: 15110652 [TBL] [Abstract][Full Text] [Related]
36. Endoscopic features of acute cellular rejection. Tabasco-Minguillán J; Hutson W; Weber K; Lee RG; Furukawa H; Abu-Elmagd K; Todo S; Rakela J Transplant Proc; 1996 Oct; 28(5):2765-6. PubMed ID: 8908047 [No Abstract] [Full Text] [Related]
37. Intestinal allograft rejection in lipopolysaccharide-hyporesponsive mice. Quan D; Zhang Z; Zhong R; Jevnikar A; Garcia B; Grant D Transplant Proc; 1996 Oct; 28(5):2460-1. PubMed ID: 8907901 [No Abstract] [Full Text] [Related]
38. SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Mengel M; Sis B; Halloran PF Am J Transplant; 2007 Oct; 7(10):2221-6. PubMed ID: 17848174 [TBL] [Abstract][Full Text] [Related]
39. SDF-1 expression is elevated in chronic human renal allograft rejection. Hoffmann U; Banas B; Krüger B; Banas M; Bergler T; Böger C; Kammerl M; Obed A; Rümmele P; Segerer S; Riegger GA; Krämer BK Clin Transplant; 2006; 20(6):712-8. PubMed ID: 17100720 [TBL] [Abstract][Full Text] [Related]
40. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management. Veiga Barreiro A; Crespo Leiro M; Doménech García N; Paniagua MJ; Vázquez Martul E; González Cuesta M; Ramírez C; Juffé Stein A; Castro Beiras A Transplant Proc; 2004 Apr; 36(3):778-9. PubMed ID: 15110660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]